WEST PALM BEACH, Fla., June 20 LAWFUEL – The Law Newswire — T…

WEST PALM BEACH, Fla., June 20 LAWFUEL – The Law Newswire — The law firm of Gulas & Stuckey, which represented the family of Adam Hendelson in a three year long legal battle with Johnson & Johnson that ended Tuesday, is preparing to take the next Duragesic law suit to trial in late summer.

The Hendelson family sued Johnson & Johnson subsidiaries JanssenPharmaceutica Products, LP, and ALZA Corp. over Adam’s death on Dec. 17, 2003. Adam died due to an overdose of the drug fentanyl when the Duragesic patch he wore due to chronic hip pain leaked.

The father of 28-year-old Adam Hendelson cried with his family outside the courtroom immediately following the federal jury’s verdict which found the Duragesic patch to have been at fault for his son’s death.

Gulas & Stuckey, his attorneys, have eight cases pending trial and more yet to be filed. Mr. Hendelson urges those families to speak up for their family members who are now silent.

“No amount of money is a comfort for the void left forever in our
hearts,” Mr. Hendelson said.

Ike Gulas of Gulas & Stuckey said Tuesday’s verdict sets a precedent
for upcoming trials. Dozens have been filed nationwide involving Duragesic, which was Johnson & Johnson’s No. 6 seller in 2006. The case was only the second to go to trial and the first to enter federal court. The first was tried in Houston, Texas, in 2006, and a state jury found in favor of the plaintiff and ordered Johnson & Johnson to pay the family $772,500. Gulas & Stuckey will take the next case to trial in Augusta, Ga., late this summer.

“We’re going to fight relentlessly for each of these families,” Gulas
said. “The manufacturers of Duragesic failed each of them by allowing an
enormously powerful drug onto the market despite its potential to

Duragesic has been under attack since February of 2004 when Janssen
issued a recall of one manufacturing lot after determining that some
patches in that lot might leak along one edge. In April of the same year
the company expanded the recall to include five lots – about 2.2 million

The recall resulted in ongoing investigation by the Food and Drug
Administration. More information about the FDA investigation is available
at http://www.fda.gov.

According to the manufacturer, Duragesic patches “contain a strong
opiate in the form of a gel.” The recall release from Janssen reads that
“exposure to too much medication can occur if the gel leaks directly onto
the skin” and that “overexposure may cause potentially life threatening

Adam Hendelson died sitting at his computer while working on his
resume. He had more than three times the lethal dosage of fentanyl in his

For more information about Duragesic and about Gulas & Stuckey, P.C.,
go to http://www.gulasandstuckey.com/PracticeAreas/duragesic.asp.

Scroll to Top